Carisma Therapeutics Inc.
Carisma Therapeutics Inc. (CARM) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 13 transactions totaling $138.2K, demonstrating a bearish sentiment with -$138.2K in net insider flow. The most recent transaction on Oct 7, 2025 involved a transaction of 56,982 shares valued at $6.3K.
CARM Insider Activity Summary
Who Is Buying CARM Stock?
No significant insider buying has been recorded for CARM in the recent period.
Who Is Selling CARM Stock?
No significant insider selling has been recorded for CARM in the recent period.
Is Carisma Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CARM is bearish with an Insider Alignment Score of 0/100 and a net flow of -$138.2K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CARM Frequently Asked Questions
Understanding CARM Insider Activity
Insider trading at Carisma Therapeutics Inc. (CARM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading CARM stock, having executed 13 transactions in the past 90 days. The most active insider is Michael Klichinsky (Executive), who has made 6 transactions totaling $144.4K.
Related Tools
Track Carisma Therapeutics Inc. Insider Activity
Get notified when executives and directors at CARM file new Form 4 transactions